Touchless Security Solutions to Make Venues Safe and the Process Easy

 

Anil Chitkara, Co-Founder and Head of Corporate Development for Evolv Technology, started his company with one goal: to keep people safe from harm at events or other venues and locations where threats could exist.

For most of Evolv’s existence, those threats were violent, either from potential terrorist attacks or an active shooter situation. But COVID-19 shined a light on a different risk to the health of the public at large. When considering entertainment spaces, security checkpoints now have a new consideration: how to make the venue safe from a deadly disease.

Chitkara discussed these scenarios and how Evolv’s touchless security solutions can help.

“We’ve all been through airports. We know what airport screening is like,” Chitkara said. “We looked at all these other places where people are and [asked], ‘How can we help the security professionals in those areas maintain a safe venue or environment?’”

Theaters, performing arts centers, concert arenas, sports venues, theme parks and amphitheaters are all focuses of Evolv’s technology solutions. The company’s goal is to take a slow and manual security process and make it faster and more comfortable for the guest to enter the venue.

The security process for many entertainment venues today is not a friendly experience, and Chitkara wants to change that.

“Not only is it not what the customer entering into the venue wants, but it also is not what the band and the concert venue want,” Chitkara said. “They want their customer to be excited from the day they purchase their ticket up to the moment they walk up to the arena. The biggest pain point of the guest experience is that security screening. There hasn’t been a great solution up to now.”

Rethinking the whole approach to security through technology and doing it in a fan-friendly way is Chitkara’s mission. Evolv’s touchless security approach makes entry easier for the patron.

And, during this time of healthcare concerns, the less security needs to come into physical contact with someone entering the venue, the lower the risk of spreading viruses.

Be sure to subscribe to our industry publication for the latest news, videos, and podcasts in the Software & Technology Industry.

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More